Cited by 70Electroconvulsive Therapy StudiesTreatment of Major DepressionTranscranial Magnetic Stimulation Studies

BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy

Kleimann, Alexandra, Kotsiari, Alexandra, Sperling, Wolfgang, Gröschl, Michael, Heberlein, Annemarie, Kahl, Kai G., Hillemacher, Thomas, Bleich, Stefan +2 more·2015·Journal of Neural Transmission

Abstract

We examined potential changes in brain-derived neurotrophic factor (BDNF) serum levels and promoter methylation of the BDNF gene in 11 patients with treatment-resistant major depressive disorder during a series of electroconvulsive therapy (ECT). Blood samples were taken before, 1 and 24 h after ECT treatment sessions 1, 4, 7 and 10. Patients remitting under ECT had significantly lower mean promoter methylation rates, especially concerning the exon I promoter, compared to non-remitters (both p < 0.002). These findings may point to a depression subtype in which ECT is particularly beneficial.

Integrity signals

Registry

Crossref · 10.1007/s00702-014-1336-6

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kleimann, A., Kotsiari, A., Sperling, W., Gröschl, M., Heberlein, A., Kahl, K. G., Hillemacher, T., Bleich, S., Kornhuber, J., & Frieling, H.
Affiliations
  • Medizinische Hochschule Hannover (DE)
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
Corresponding author
Kleimann, Alexandra
Venue
Journal of Neural Transmission
Published
2014-11-12
Volume
122
Issue
6
Pages
925-928
ISSN
  • 0300-9564 (ISSN-L)
  • 1435-1463
OpenAlex
W1989863639
Cited by
70
References
11
Citations by year
2026: 2 · 2025: 4 · 2024: 6 · 2023: 6 · 2022: 7 · 2021: 6 · 2020: 6 · 2019: 8 · 2018: 9 · 2017: 7 · 2016: 6 · 2015: 3
FWCI
4.07
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neural Transmission (publishedVersion)
  • PubMed (publishedVersion)
Funders
Medizinischen Hochschule Hannover
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
Keywords
brain-derived neurotrophic factor, electroconvulsive therapy, depression remission, depression subtypes, epigenetic regulation
MeSH terms
Major Depressive Disorder, Depressive Disorder, Major, Electroconvulsive Therapy, Exons, Female, Humans, Male, Middle Aged, Promoter Regions, Genetic, Prospective Studies, Treatment Outcome, DNA Methylation, Brain-Derived Neurotrophic Factor, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review